(NewsNation) — ALS, or amyotrophic lateral sclerosis, is a fatal neurological disease with no cure. For people who carry genetic mutations linked to the disease, one of the biggest challenges is not knowing when symptoms might begin.
New research funded by the National Institutes of Health could help change that.
Researchers have developed a blood test that may predict when an at-risk person is likely to develop ALS symptoms, providing a potential window for preventive treatment before irreversible nerve damage occurs.
The study identified protein markers in the blood that can help predict the onset of symptoms, a transition known as phenoconversion.
Dr. Anthony Youn says popular peptides 'aren't studied enough' in humans

#Help #blood #national #researchers